Track the 헬릭스미스 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 헬릭스미스 has logged 14 reports. Market capitalisation: €138.1bn. The latest transaction was disclosed on 4 May 2026 (Sale). Among the most active insiders: 김선영. All data is openly available.
14
Insider Decl.
n/a
Thresholds
n/a
1 ops.
Buy Volume
n/a
2 ops.
Sell Volume
Fundamental score
Ranked 19,869 of 29,156 companies
39.8
score / 100
Value
26
Quality
53
FCF yld-5.2%
Earn yld-0.3%
EV/EBITDA·
ROE·
Gross mgn38%
Net mgn-17%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Helixmith is a company specializing in the health and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative therapies to treat serious diseases.